Filed: 2/14/2024ACC: 0001420506-24-000478
📋 What this filing means
BRAIDWELL LP filed this quarterly 13F‑HR report disclosing 72 equity positions with a total reported market value of $2.72B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
72
Positions
$2.72B
Total AUM (reported)
1.65B
Total Shares
Allocation by class
COM$1.13B41.4%
NOTE 11/1$189.12M6.9%
NOTE 2.500% 3/1$138.41M5.1%
NOTE 2.250% 4/0$130.39M4.8%
NOTE 0.375% 3/0$123.14M4.5%
NOTE 11/0$117.92M4.3%
NOTE 0.375% 3/1$74.29M2.7%
Portfolio Concentration
Top 3$457.91M16.8%
4–10$639.17M23.5%
11–25$782.20M28.7%
Rest$843.40M31.0%
Top 3 weight
16.8%
Top 10 weight
40.3%
Voting Authority Distribution
Total shares with voting rights: 1.65B
Sole
Full voting authority
1.65B
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole72
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings72
Rows:
GUARDANT HEALTH INC
SOLEShares268.25M
TypePRN
Market value$189.12M
6.95%
Sole
268.25M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares114.34M
TypePRN
Market value$138.41M
5.08%
Sole
114.34M
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares126.90M
TypePRN
Market value$130.39M
4.79%
Sole
126.90M
Shared
0.00
None
0.00
EXACT SCIENCES CORP
SOLEShares131M
TypePRN
Market value$123.14M
4.52%
Sole
131M
Shared
0.00
None
0.00
NOVOCURE LTD
SOLEShares135.83M
TypePRN
Market value$117.92M
4.33%
Sole
135.83M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares715.21K
TypeSH
Market value$94.24M
3.46%
Sole
715.21K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares1.29M
TypeSH
Market value$81.01M
2.98%
Sole
1.29M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares1.65M
TypeSH
Market value$75.88M
2.79%
Sole
1.65M
Shared
0.00
None
0.00
NUVASIVE INC
SOLEShares80.53M
TypePRN
Market value$74.29M
2.73%
Sole
80.53M
Shared
0.00
None
0.00
INSULET CORP
SOLEShares63M
TypePRN
Market value$72.70M
2.67%
Sole
63M
Shared
0.00
None
0.00
TANDEM DIABETES CARE INC
SOLEShares71.05M
TypePRN
Market value$67.18M
2.47%
Sole
71.05M
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares4.22M
TypeSH
Market value$61.55M
2.26%
Sole
4.22M
Shared
0.00
None
0.00
IRHYTHM TECHNOLOGIES INC
SOLEShares568.16K
TypeSH
Market value$60.82M
2.23%
Sole
568.16K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares153.20K
TypeSH
Market value$58.28M
2.14%
Sole
153.20K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares67.29M
TypePRN
Market value$57.33M
2.11%
Sole
67.29M
Shared
0.00
None
0.00
INSMED INC
SOLEShares52.39M
TypePRN
Market value$56.12M
2.06%
Sole
52.39M
Shared
0.00
None
0.00
PENUMBRA INC
SOLEShares222.79K
TypeSH
Market value$56.04M
2.06%
Sole
222.79K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares50.67M
TypePRN
Market value$51.52M
1.89%
Sole
50.67M
Shared
0.00
None
0.00
NEOGENOMICS INC
SOLEShares65.60M
TypePRN
Market value$50.20M
1.84%
Sole
65.60M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares56.03M
TypePRN
Market value$47.70M
1.75%
Sole
56.03M
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares45M
TypePRN
Market value$47.20M
1.73%
Sole
45M
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares1.12M
TypeSH
Market value$44.49M
1.63%
Sole
1.12M
Shared
0.00
None
0.00
PARAGON 28 INC
SOLEShares3.36M
TypeSH
Market value$41.79M
1.53%
Sole
3.36M
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares611.37K
TypeSH
Market value$41.77M
1.53%
Sole
611.37K
Shared
0.00
None
0.00
THERMO FISHER SCIENTIFIC INC
SOLEShares75.75K
TypeSH
Market value$40.21M
1.48%
Sole
75.75K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INCSOLE | NOTE 11/1 | 268.25M | PRN | $189.12M 6.95% | 268.25M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 114.34M | PRN | $138.41M 5.08% | 114.34M | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | NOTE 2.250% 4/0 | 126.90M | PRN | $130.39M 4.79% | 126.90M | 0.00 | 0.00 |
EXACT SCIENCES CORPSOLE | NOTE 0.375% 3/0 | 131M | PRN | $123.14M 4.52% | 131M | 0.00 | 0.00 |
NOVOCURE LTDSOLE | NOTE 11/0 | 135.83M | PRN | $117.92M 4.33% | 135.83M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 715.21K | SH | $94.24M 3.46% | 715.21K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 1.29M | SH | $81.01M 2.98% | 1.29M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 1.65M | SH | $75.88M 2.79% | 1.65M | 0.00 | 0.00 |
NUVASIVE INCSOLE | NOTE 0.375% 3/1 | 80.53M | PRN | $74.29M 2.73% | 80.53M | 0.00 | 0.00 |
INSULET CORPSOLE | NOTE 0.375% 9/0 | 63M | PRN | $72.70M 2.67% | 63M | 0.00 | 0.00 |
TANDEM DIABETES CARE INCSOLE | NOTE 1.500% 5/0 | 71.05M | PRN | $67.18M 2.47% | 71.05M | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 4.22M | SH | $61.55M 2.26% | 4.22M | 0.00 | 0.00 |
IRHYTHM TECHNOLOGIES INCSOLE | COM | 568.16K | SH | $60.82M 2.23% | 568.16K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 153.20K | SH | $58.28M 2.14% | 153.20K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.250% 2/0 | 67.29M | PRN | $57.33M 2.11% | 67.29M | 0.00 | 0.00 |
INSMED INCSOLE | NOTE 1.750% 1/1 | 52.39M | PRN | $56.12M 2.06% | 52.39M | 0.00 | 0.00 |
PENUMBRA INCSOLE | COM | 222.79K | SH | $56.04M 2.06% | 222.79K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | NOTE 1.250% 9/1 | 50.67M | PRN | $51.52M 1.89% | 50.67M | 0.00 | 0.00 |
NEOGENOMICS INCSOLE | NOTE 0.250% 1/1 | 65.60M | PRN | $50.20M 1.84% | 65.60M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | NOTE 2.500% 9/1 | 56.03M | PRN | $47.70M 1.75% | 56.03M | 0.00 | 0.00 |
DEXCOM INCSOLE | NOTE 0.250%11/1 | 45M | PRN | $47.20M 1.73% | 45M | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 1.12M | SH | $44.49M 1.63% | 1.12M | 0.00 | 0.00 |
PARAGON 28 INCSOLE | COM | 3.36M | SH | $41.79M 1.53% | 3.36M | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 611.37K | SH | $41.77M 1.53% | 611.37K | 0.00 | 0.00 |
THERMO FISHER SCIENTIFIC INCSOLE | COM | 75.75K | SH | $40.21M 1.48% | 75.75K | 0.00 | 0.00 |
Page 1 of 3